Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)

Marc C. Hochberg, Donna L. Perlmutter, Thomas A. Medsger, Katherine Nguyen, Virginia Steen, Michael H. Weisman, Barbara White, Fredrick Wigley

Research output: Contribution to journalArticle

Abstract

Objective. To examine the possible association between augmentation mammoplasty and systemic sclerosis (SSc; scleroderma). Methods. Eight hundred thirty-seven women with a clinical diagnosis of SSc, recruited as a volunteer sample from 3 university-based, tertiary care scleroderma clinical research centers, and 2,507 race-matched local control women, recruited by the technique of random-digit-dialing and frequency-matched on age, completed a questionnaire providing data on history of augmentation mammoplasty, including possible complications of the procedure. The odds ratio (OR) and 95 percent confidence interval (95% CI) for the association of augmentation mammoplasty with SSc were estimated by multivariate logistic regression analysis with adjustment for age, race and center, and by conditional logistic regression analysis with adjustment for age. Results. Eleven (1.31%) of the 837 cases reported a history of augmentation mammoplasty prior to diagnosis of SSc, compared with 31 (1.24%) of the 2,507 controls. The adjusted OR from the unmatched analysis was 1.07 (95% CI 0.53-2.13), while that from the matched analysis was 1.11 (95% CI 0.55-2.24). Conclusion. These results fail to demonstrate a significant association between augmentation mammoplasty and SSc, and are consistent with those reported from other epidemiologic studies.

Original languageEnglish (US)
Pages (from-to)1125-1131
Number of pages7
JournalArthritis and Rheumatism
Volume39
Issue number7
DOIs
StatePublished - Jul 1996

Fingerprint

Mammaplasty
Systemic Scleroderma
Confidence Intervals
Logistic Models
Odds Ratio
Regression Analysis
Tertiary Healthcare
Epidemiologic Studies
Volunteers
Research

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Hochberg, M. C., Perlmutter, D. L., Medsger, T. A., Nguyen, K., Steen, V., Weisman, M. H., ... Wigley, F. (1996). Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis and Rheumatism, 39(7), 1125-1131. https://doi.org/10.1002/art.1780390708

Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). / Hochberg, Marc C.; Perlmutter, Donna L.; Medsger, Thomas A.; Nguyen, Katherine; Steen, Virginia; Weisman, Michael H.; White, Barbara; Wigley, Fredrick.

In: Arthritis and Rheumatism, Vol. 39, No. 7, 07.1996, p. 1125-1131.

Research output: Contribution to journalArticle

Hochberg, MC, Perlmutter, DL, Medsger, TA, Nguyen, K, Steen, V, Weisman, MH, White, B & Wigley, F 1996, 'Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)', Arthritis and Rheumatism, vol. 39, no. 7, pp. 1125-1131. https://doi.org/10.1002/art.1780390708
Hochberg MC, Perlmutter DL, Medsger TA, Nguyen K, Steen V, Weisman MH et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis and Rheumatism. 1996 Jul;39(7):1125-1131. https://doi.org/10.1002/art.1780390708
Hochberg, Marc C. ; Perlmutter, Donna L. ; Medsger, Thomas A. ; Nguyen, Katherine ; Steen, Virginia ; Weisman, Michael H. ; White, Barbara ; Wigley, Fredrick. / Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). In: Arthritis and Rheumatism. 1996 ; Vol. 39, No. 7. pp. 1125-1131.
@article{ce62313be47f48baa31b143a98e7ebc5,
title = "Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)",
abstract = "Objective. To examine the possible association between augmentation mammoplasty and systemic sclerosis (SSc; scleroderma). Methods. Eight hundred thirty-seven women with a clinical diagnosis of SSc, recruited as a volunteer sample from 3 university-based, tertiary care scleroderma clinical research centers, and 2,507 race-matched local control women, recruited by the technique of random-digit-dialing and frequency-matched on age, completed a questionnaire providing data on history of augmentation mammoplasty, including possible complications of the procedure. The odds ratio (OR) and 95 percent confidence interval (95{\%} CI) for the association of augmentation mammoplasty with SSc were estimated by multivariate logistic regression analysis with adjustment for age, race and center, and by conditional logistic regression analysis with adjustment for age. Results. Eleven (1.31{\%}) of the 837 cases reported a history of augmentation mammoplasty prior to diagnosis of SSc, compared with 31 (1.24{\%}) of the 2,507 controls. The adjusted OR from the unmatched analysis was 1.07 (95{\%} CI 0.53-2.13), while that from the matched analysis was 1.11 (95{\%} CI 0.55-2.24). Conclusion. These results fail to demonstrate a significant association between augmentation mammoplasty and SSc, and are consistent with those reported from other epidemiologic studies.",
author = "Hochberg, {Marc C.} and Perlmutter, {Donna L.} and Medsger, {Thomas A.} and Katherine Nguyen and Virginia Steen and Weisman, {Michael H.} and Barbara White and Fredrick Wigley",
year = "1996",
month = "7",
doi = "10.1002/art.1780390708",
language = "English (US)",
volume = "39",
pages = "1125--1131",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma)

AU - Hochberg, Marc C.

AU - Perlmutter, Donna L.

AU - Medsger, Thomas A.

AU - Nguyen, Katherine

AU - Steen, Virginia

AU - Weisman, Michael H.

AU - White, Barbara

AU - Wigley, Fredrick

PY - 1996/7

Y1 - 1996/7

N2 - Objective. To examine the possible association between augmentation mammoplasty and systemic sclerosis (SSc; scleroderma). Methods. Eight hundred thirty-seven women with a clinical diagnosis of SSc, recruited as a volunteer sample from 3 university-based, tertiary care scleroderma clinical research centers, and 2,507 race-matched local control women, recruited by the technique of random-digit-dialing and frequency-matched on age, completed a questionnaire providing data on history of augmentation mammoplasty, including possible complications of the procedure. The odds ratio (OR) and 95 percent confidence interval (95% CI) for the association of augmentation mammoplasty with SSc were estimated by multivariate logistic regression analysis with adjustment for age, race and center, and by conditional logistic regression analysis with adjustment for age. Results. Eleven (1.31%) of the 837 cases reported a history of augmentation mammoplasty prior to diagnosis of SSc, compared with 31 (1.24%) of the 2,507 controls. The adjusted OR from the unmatched analysis was 1.07 (95% CI 0.53-2.13), while that from the matched analysis was 1.11 (95% CI 0.55-2.24). Conclusion. These results fail to demonstrate a significant association between augmentation mammoplasty and SSc, and are consistent with those reported from other epidemiologic studies.

AB - Objective. To examine the possible association between augmentation mammoplasty and systemic sclerosis (SSc; scleroderma). Methods. Eight hundred thirty-seven women with a clinical diagnosis of SSc, recruited as a volunteer sample from 3 university-based, tertiary care scleroderma clinical research centers, and 2,507 race-matched local control women, recruited by the technique of random-digit-dialing and frequency-matched on age, completed a questionnaire providing data on history of augmentation mammoplasty, including possible complications of the procedure. The odds ratio (OR) and 95 percent confidence interval (95% CI) for the association of augmentation mammoplasty with SSc were estimated by multivariate logistic regression analysis with adjustment for age, race and center, and by conditional logistic regression analysis with adjustment for age. Results. Eleven (1.31%) of the 837 cases reported a history of augmentation mammoplasty prior to diagnosis of SSc, compared with 31 (1.24%) of the 2,507 controls. The adjusted OR from the unmatched analysis was 1.07 (95% CI 0.53-2.13), while that from the matched analysis was 1.11 (95% CI 0.55-2.24). Conclusion. These results fail to demonstrate a significant association between augmentation mammoplasty and SSc, and are consistent with those reported from other epidemiologic studies.

UR - http://www.scopus.com/inward/record.url?scp=0029999820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029999820&partnerID=8YFLogxK

U2 - 10.1002/art.1780390708

DO - 10.1002/art.1780390708

M3 - Article

C2 - 8670320

AN - SCOPUS:0029999820

VL - 39

SP - 1125

EP - 1131

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -